Novartis and GSK step up seasonal and swine flu vaccine campaigns
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has received new orders for 96 million doses of its pandemic (H1N1) adjuvanted influenza vaccine from nine countries, bringing the total number of doses ordered to 291 million.